Medpace

1 stories · following the connections

Business

Ritter Pharmaceuticals Selects Medpace as its Clinical Research Organization for Pivotal Phase 3 Clinical Trial of RP-G28 in Lactose Intolerance

By Nasdaq OMXMay 3, 2018, 10:00 AM UTC